EFFICACY AND DURABILITY OF FOSTEMSAVIR, IBALIZUMAB, OR LENACAPAVIR-INCLUDING REGIMENS IN PEOPLE LIVING WITH MULTIDRUG-RESISTANT HIV-1: RESULTS FROM THE PRESTIGIO REGISTRY

Conference Reports for NATAP

19th European AIDS Conference
October 18th-21st , 2023
Warsaw, Poland


EFFICACY AND DURABILITY OF FOSTEMSAVIR, IBALIZUMAB, OR LENACAPAVIR-INCLUDING REGIMENS IN PEOPLE LIVING WITH MULTIDRUG-RESISTANT HIV-1: RESULTS FROM THE PRESTIGIO REGISTRY

	EACS 2023 Oct 21 Poster ODF attached Download the PDF here